Gamida Cell’s Bone Marrow Transplant Alternative Succeeds In Phase III

 
• By Mandy Jackson
  
Young adult woman walking up the stairs with sun sport background.
Gamida Cell's omidubicel is on the path to US FDA submission • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D